Vanguard Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Vanguard Capital Management's ABUS Position: Q3 2026 in Review
Vanguard Capital Management reduced its Arbutus Biopharma (ABUS) stake by 0.32% in Q3 2026, selling an estimated $108K and leaving 6,988,183 shares worth $33.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2117.
Vanguard Capital Management first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. The position peaked at $33.7M in Q2 2026. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Vanguard Capital Management held 6,988,183 shares of Arbutus Biopharma worth $33.4M as of Q3 2026.
- Vanguard Capital Management sold 22,496 Arbutus Biopharma shares in Q3 2026, an estimated $108K.
- Arbutus Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2117 holding.
- Vanguard Capital Management first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Arbutus Biopharma position peaked at $33.7M in Q2 2026.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.